ASX Announcements

Investor Centre

ASX Announcements

November 2009

24/11/2009 Becoming a substantial holder

24/11/2009 Appendix 3B

24/11/2009 Cleansing Statement

18/11/2009 Starpharma announces $15.6 million capital raising

18/11/2009 Reinstatement to Official Quotation

16/11/2009 Suspension from Official Quotation Request

13/11/2009 Results of Meeting

12/11/2009 AGM Chairman's and CEO's Presentations

12/11/2009 Trading Halt

05/11/2009 Starpharma signs agrochemicals deal

October 2009

29/10/2009 New legislation results in withdrawal of CEO incentives scheme

23/10/2009 Appendix 4C

12/10/2009 Notice of Annual General Meeting/Proxy Form

September 2009

30/9/2009 Annual Report to shareholders

22/9/2009 US Patent Grant Extends VivaGel Coverage to 2024

18/9/2009 Release of Shares From Escrow

17/9/2009 Shareholder Update

August 2009

24/8/2009 Preliminary Final Report

04/8/2009 Interim Financial Results - Material Improvement

03/8/2009 VivaGel - Anti-HIV and Herpes Activity following human administration

July 2009

27/7/2009 Appendix 4C

June 2009

30/6/2009 Appendix 3B - Employee Share Options

30/6/2009 Lapse of unquoted options

02/6/2009 Shareholder Update: June 2009

May 2009

25/5/2009 Change in substantial holding

22/5/2009 Appendix 3B

22/5/2009 Appendix 3B

22/5/2009 Cleansing Statement

21/5/2009 Completes $7.1m capital raising

13/5/2009 CEO Investor Presentation

11/5/2009 Elanco deal triggers Starpharma SPP extension

11/5/2009 Starpharma and Elanco sign agreement

05/5/2009 Share Purchase Plan Extension

April 2009

30/4/2009 Shareholder Update: May 2009

22/4/2009 Share Purchase Plan

16/4/2009 Change in substantial holding

08/4/2009 Appendix 3B

08/4/2009 Cleansing Statement

07/4/2009 Appendix 4C

07/4/2009 Raises additional capital via institutional placement

03/4/2009 Trading Halt Request

03/4/2009 Trading Halt

March 2009

19/3/2009 Completes patient testing in retention of activity study

February 2009

19/2/2009 Half Yearly Report and Accounts

10/2/2009 Topical Microbicide Field Boost With Efficacy Result

09/2/2009 Lapse of unquoted options

January 2009

30/1/2009 Appendix 4C

2018 2017 2016 20152014 2013 2012 2011 2010 2009 2008 2007 2006 2005 2004 2003 2002 2001

To access ASX releases in prior years to those listed below please visit the ASX website and enter ASX Code SPL.

© Starpharma Holdings Limited 2017